Literature DB >> 8785587

Induction of human monocyte motility by lysyl oxidase.

H M Lazarus1, W W Cruikshank, N Narasimhan, H M Kagan, D M Center.   

Abstract

Lysyl oxidase highly purified from calf aorta was found to be a potent chemotactic agent for unstimulated human peripheral blood mononuclear cells, determined in in vitro assays in Boyden chambers. A typical chemotactic bell-shaped curve was observed, with a maximal migratory response of 237% of control occurring at 10(-10) M lysyl oxidase. The chemotactic response was prevented by prior heat inactivation of the enzyme, by treatment of the enzyme with beta-aminopropionitrile or ethylenediamine, which are active site-directed inhibitors of lysyl oxidase, and by a competing, lysine-containing peptide substrate of lysyl oxidase. The chemoattractant response to lysyl oxidases was characterized by both chemokinetic and chemotactic components. These results raise the possibility that extracellular lysyl oxidase may have important roles to play in biology in addition to its established function in the crosslinking of elastin and collagen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8785587     DOI: 10.1016/s0945-053x(05)80015-0

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  27 in total

1.  Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression.

Authors:  Rhiannon M Kelsh; Paula J McKeown-Longo
Journal:  Trends Cancer Res       Date:  2013-01-01

2.  Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer.

Authors:  Shulamit Sebban; Regina Golan-Gerstl; Rotem Karni; Olga Vaksman; Ben Davidson; Reuven Reich
Journal:  Clin Exp Metastasis       Date:  2012-07-18       Impact factor: 5.150

3.  Localization and activity of lysyl oxidase within nuclei of fibrogenic cells.

Authors:  W Li; K Nellaiappan; T Strassmaier; L Graham; K M Thomas; H M Kagan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.

Authors:  Quynh-Thu Le; Jonathan Harris; Anthony M Magliocco; Christina S Kong; Roman Diaz; Brian Shin; Hongbin Cao; Andy Trotti; Janine T Erler; Christine H Chung; Adam Dicker; Thomas F Pajak; Amato J Giaccia; K Kian Ang
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

5.  Functional consequences of mitochondrial DNA deletions in human skin fibroblasts: increased contractile strength in collagen lattices is due to oxidative stress-induced lysyl oxidase activity.

Authors:  Marc Majora; Tanja Wittkampf; Bianca Schuermann; Maren Schneider; Susanne Franke; Susanne Grether-Beck; Ekkehard Wilichowski; Françoise Bernerd; Peter Schroeder; Jean Krutmann
Journal:  Am J Pathol       Date:  2009-08-06       Impact factor: 4.307

6.  Dysregulation of Lysyl Oxidase Expression in Lesions and Endometrium of Women With Endometriosis.

Authors:  Lynnette A Ruiz; Perla M Báez-Vega; Abigail Ruiz; Daniëlle P Peterse; Janice B Monteiro; Nabal Bracero; Pedro Beauchamp; Asgerally T Fazleabas; Idhaliz Flores
Journal:  Reprod Sci       Date:  2015-05-11       Impact factor: 3.060

7.  Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.

Authors:  Neill Patani; Wen Jiang; Robert Newbold; Kefah Mokbel
Journal:  J Carcinog       Date:  2010-11-12

8.  Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis.

Authors:  Pawan Kumar; Arti Yadav; Samip N Patel; Mozaffarul Islam; Quintin Pan; Sofia D Merajver; Theodoros N Teknos
Journal:  Mol Cancer       Date:  2010-08-03       Impact factor: 27.401

9.  Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells.

Authors:  Héctor A Lucero; Katya Ravid; Jessica L Grimsby; Celeste B Rich; Sandra J DiCamillo; Joni M Mäki; Johanna Myllyharju; Herbert M Kagan
Journal:  J Biol Chem       Date:  2008-06-27       Impact factor: 5.157

10.  The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells.

Authors:  Alla Bondareva; Charlene M Downey; Fabio Ayres; Wei Liu; Steven K Boyd; Benedikt Hallgrimsson; Frank R Jirik
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.